QSI · XBRL financial data
Quantum-Si financial statements, every fiscal year
The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (QSI's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | †Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Revenue from contracts with customers | — | 0 | 0 | 1,082 | 3,058 | 2,436 |
| Cost of revenue | — | 0 | 0 | 594 | 1,458 | 1,283 |
| Gross profit | — | 0 | 0 | 488 | 1,600 | 1,153 |
| Research and development | 27,555 | 46,575 | 72,062 | 67,025 | 59,641 | 53,759 |
| Selling, general and administrative | 9,136 | 50,333 | 42,296 | 44,634 | 50,535 | 44,754 |
| General and administrative | 7,984 | 46,377 | — | — | — | — |
| Total operating expenses | 36,691 | 96,908 | 123,841 | 111,659 | 110,176 | 117,252 |
| Operating income (loss) | (36,691) | (96,908) | (123,841) | (111,171) | (108,576) | (116,099) |
| Interest income | — | — | 0 | 459 | 9,638 | 8,964 |
| Interest expense | 9 | 5 | 0 | — | — | — |
| Other income (expense) | (10) | (5,004) | (20,145) | 366 | (19) | 955 |
| Income tax expense (benefit) | 0 | 0 | 0 | 0 | 56 | 58 |
| Net income (loss) | (36,613) | (94,989) | (132,442) | (95,960) | (101,007) | (101,339) |
| Earnings per share, basic USD per share | (6.84) | (1.19) | (0.95) | (0.68) | (0.71) | (0.51) |
| Earnings per share, diluted USD per share | (6.84) | (1.19) | (0.95) | (0.68) | (0.71) | (0.51) |
| Weighted average shares, basic thousands of shares | 5,355 | 79,579 | 139,255 | 141,300 | 143,196 | 197,765 |
| Weighted average shares, diluted thousands of shares | 5,355 | 79,579 | 139,255 | 141,300 | 143,196 | 197,765 |
- † Share count changed about 15x in the period ending 2021-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Balance sheet
CSVFiscal years (QSI's year ends in late December)
- † Share count changed about 15x in the period ending 2021-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Cash flows
CSVFiscal years (QSI's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | †Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Net income (loss) | (36,613) | (94,989) | (132,442) | (95,960) | (101,007) | (101,339) |
| Stock-based compensation | 1,924 | 24,918 | 11,206 | 8,516 | 8,887 | 10,773 |
| Depreciation and amortization | 894 | 1,041 | 2,584 | 4,156 | 4,600 | 4,454 |
| Net cash from operating activities | (32,573) | (66,813) | (90,560) | (94,036) | (87,795) | (94,717) |
| Purchases of property and equipment | 461 | 5,763 | 10,741 | 4,510 | 4,583 | 2,517 |
| Net cash from investing activities | (461) | (450,937) | 137,185 | 143,428 | (32,675) | (28,320) |
| Proceeds from issuing common stock | — | — | 0 | 0 | 34,789 | 0 |
| Net cash from financing activities | 37,014 | 516,625 | 1,909 | 149 | 35,876 | 95,423 |
| Net change in cash | — | — | 48,534 | 49,541 | (84,619) | (27,602) |
- † Share count changed about 15x in the period ending 2021-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Compare with peers
SIC 3829 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3829 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
- A cell reading “not reported” means the filings give no figure for that quarter alone.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Quantum-Si | 23,653 | 344 | (18,444)* | not reported | 6.1 quarters | 10-QJun 30, 2026 |
| Frequency Electronics | 61,407 | 23,451 | 2,622 | 11.3M | — | 10-QJul 31, 2026 |
| Quanterix | 44,169 | 32,906 | (5,119)* | 47.3M | 18.3 quarters | 10-QJun 30, 2026 |
| Mesa Laboratories | 30,695 | 60,138 | 14,736 | 5.6M | — | 10-QJun 30, 2026 |
| Pacific Biosciences of California | 61,003 | 39,007 | (35,583)* | 310.8M | 6.7 quarters | 10-QJun 30, 2026 |
| Senseonics Holdings | 44,753 | 14,483 | (30,138)* | 52.9M | 4.7 quarters | 10-QJun 30, 2026 |
| Cytek Biosciences | 66,806 | 53,229 | not reported | 130.8M | — | 10-QSep 30, 2026 |
| 908 Devices | 63,019 | 16,074 | 3,171* | 41.3M | — | 10-QJun 30, 2026 |
| Allient | 39,646 | 164,399 | 1,957* | 17.0M | — | 10-QSep 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.
